Search
Now showing items 1-1 of 1
(Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2016)
Objective This study sought to determine whether changes in neurodevelopmental outcomes between 18 and 36 months of age were associated with prenatal exposure to triptan medications, a class of 5-HT receptor agonists used ...